Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Other financing activities: 2015-2016

Historic Other financing activities for Intellia Therapeutics (NTLA) over the last 1 years, with Sep 2016 value amounting to $1.7 million.

  • Intellia Therapeutics' Other financing activities was N/A to $1.7 million in Q3 2016 from the same period last year, while for Sep 2016 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $424,000 for FY2018, which is N/A change from last year.
  • As of Q3 2016, Intellia Therapeutics' Other financing activities stood at $1.7 million, which was up 669.30% from $215,000 recorded in Q2 2016.
  • Intellia Therapeutics' 5-year Other financing activities high stood at $1.7 million for Q3 2016, and its period low was $207,000 during Q4 2015.
  • Its 2-year average for Other financing activities is $742,750, with a median of $555,000 in 2016.